# Carisoprodol Tablets, USP, 350 mg

NDC: 63561-0127
Generic name: Carisoprodol
Labeler / Manufacturer: Granulation Technology, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20250611

FDA application: ANDA211789

## Active ingredients

- CARISOPRODOL: 350 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63561-0127"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63561-0127
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2abd11e4-8ce4-4aeb-87c4-3af94c197714